Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : : workshop summary / / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resist...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Washington, District of Columbia : : National Academies Press,, [2013] 2013 |
Year of Publication: | 2013 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (170 pages) :; illustrations (some color) |
Notes: |
|
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5003379261 |
---|---|
ctrlnum |
(MiAaPQ)5003379261 (Au-PeEL)EBL3379261 (CaPaEBR)ebr10863916 (OCoLC)823904672 |
collection |
bib_alma |
record_format |
marc |
spelling |
Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB (2012 : Washington, D.C.), issuing body. Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, District of Columbia : National Academies Press, [2013] 2013 1 online resource (170 pages) : illustrations (some color) text rdacontent computer rdamedia online resource rdacarrier "Forum on drug discovery, development, and translation."--Cover. "Workshop was held on July 31- August 1, 2012 in Washington, D.C. Includes bibliographical references (pages 111-113). Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions. To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB) a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin) face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks ; The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain ; What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]) ; The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration ; Identification of potential innovative solutions to the problem. Description based on print version record. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Multidrug-resistant tuberculosis Prevention Congresses. Business logistics Congresses. International cooperation Congresses. Electronic books. Nicholson, Anna, contributor. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body. Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body. Print version: Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary. Washington, District of Columbia : National Academies Press, [2013] xvii, 152 pages ; 24 cm 9780309265959 (OCoLC)ocn828139251 (DLC)10863916 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379261 Click to View |
language |
English |
format |
Conference Proceeding eBook |
author2 |
Nicholson, Anna, Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Board on Health Sciences Policy, |
author_facet |
Nicholson, Anna, Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Board on Health Sciences Policy, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Washington, D.C.), |
author2_variant |
a n an |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
author_corporate |
Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Washington, D.C.), |
author_sort |
Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Washington, D.C.), |
title |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / |
spellingShingle |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions. |
title_sub |
workshop summary / |
title_full |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
title_fullStr |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
title_full_unstemmed |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
title_auth |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / |
title_new |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : |
title_sort |
developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / |
publisher |
National Academies Press, |
publishDate |
2013 |
physical |
1 online resource (170 pages) : illustrations (some color) |
contents |
Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions. |
isbn |
9780309265966 9780309265959 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC311 |
callnumber-sort |
RC 3311.1 W67 42012 |
genre |
Electronic books. |
genre_facet |
Congresses. Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379261 |
illustrated |
Illustrated |
dewey-hundreds |
300 - Social sciences |
dewey-tens |
360 - Social problems & social services |
dewey-ones |
362 - Social welfare problems & services |
dewey-full |
362.19699/5 |
dewey-sort |
3362.19699 15 |
dewey-raw |
362.19699/5 |
dewey-search |
362.19699/5 |
oclc_num |
823904672 |
work_keys_str_mv |
AT workshopondevelopingandstrengtheningtheglobalsupplychainforsecondlinedrugsformultidrugresistanttbwashingtondc developingandstrengtheningtheglobalsupplychainforsecondlinedrugsformultidrugresistanttuberculosisworkshopsummary AT nicholsonanna developingandstrengtheningtheglobalsupplychainforsecondlinedrugsformultidrugresistanttuberculosisworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation developingandstrengtheningtheglobalsupplychainforsecondlinedrugsformultidrugresistanttuberculosisworkshopsummary AT instituteofmedicineusboardonhealthsciencespolicy developingandstrengtheningtheglobalsupplychainforsecondlinedrugsformultidrugresistanttuberculosisworkshopsummary |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5003379261 (Au-PeEL)EBL3379261 (CaPaEBR)ebr10863916 (OCoLC)823904672 |
is_hierarchy_title |
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary / |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1792330867452936193 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05508nam a2200517 i 4500</leader><controlfield tag="001">5003379261</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">130814t20132013dcua ob 100 0 eng|d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309265959</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309265959</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309265966</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003379261</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3379261</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10863916</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)823904672</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC311.1</subfield><subfield code="b">.W67 2012</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.19699/5</subfield><subfield code="2">23</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB</subfield><subfield code="d">(2012 :</subfield><subfield code="c">Washington, D.C.),</subfield><subfield code="j">issuing body.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis :</subfield><subfield code="b">workshop summary /</subfield><subfield code="c">Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, District of Columbia :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (170 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Forum on drug discovery, development, and translation."--Cover.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Workshop was held on July 31- August 1, 2012 in Washington, D.C.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 111-113).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB) a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin) face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks ; The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain ; What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]) ; The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration ; Identification of potential innovative solutions to the problem.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multidrug-resistant tuberculosis</subfield><subfield code="x">Prevention</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Business logistics</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">International cooperation</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholson, Anna,</subfield><subfield code="e">contributor.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Board on Health Sciences Policy,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB</subfield><subfield code="t">Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary.</subfield><subfield code="d">Washington, District of Columbia : National Academies Press, [2013]</subfield><subfield code="h">xvii, 152 pages ; 24 cm</subfield><subfield code="z">9780309265959</subfield><subfield code="w">(OCoLC)ocn828139251</subfield><subfield code="w">(DLC)10863916</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3379261</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |